More tools:Markets·Screener·Research·Chat

Eton Pharmaceutcials, Inc. Common Stock (ETON) Financial Statements

Eton Pharmaceutcials, Inc. Common Stock
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG00H0KCMW0
XNAS · usd
58.81▼ 0.53 (-0.90%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close59.35
Day's Range56.11 – 59.98
52-Week Range14.27 – 66.37
Volume386.7K
Avg Volume616.9K
Share Statistics
Shares Outstanding
Employees44
ExchangeXNAS
Listed2018-11-14
Share count as of August 11, 2026
Loading Income Statement…
Key questions about Eton Pharmaceutcials, Inc. Common Stock (ETON)
What is Eton Pharmaceutcials, Inc. Common Stock's Market Cap?
Eton Pharmaceutcials, Inc. Common Stock's Market Cap is $1.7B, based on as-reported figures from SEC (XBRL) filings.
What is Eton Pharmaceutcials, Inc. Common Stock's Enterprise Value?
Eton Pharmaceutcials, Inc. Common Stock's Enterprise Value is $1.7B, based on as-reported figures from SEC (XBRL) filings.
What is Eton Pharmaceutcials, Inc. Common Stock's Trailing P/E?
Eton Pharmaceutcials, Inc. Common Stock's Trailing P/E is 132.5×, based on as-reported figures from SEC (XBRL) filings.
What is Eton Pharmaceutcials, Inc. Common Stock's Price / Sales?
Eton Pharmaceutcials, Inc. Common Stock's Price / Sales is 15.9×, based on as-reported figures from SEC (XBRL) filings.
What is Eton Pharmaceutcials, Inc. Common Stock's EV / Revenue?
Eton Pharmaceutcials, Inc. Common Stock's EV / Revenue is 15.9×, based on as-reported figures from SEC (XBRL) filings.
What is Eton Pharmaceutcials, Inc. Common Stock's EV / EBITDA?
Eton Pharmaceutcials, Inc. Common Stock's EV / EBITDA is 81.4×, based on as-reported figures from SEC (XBRL) filings.
What is Eton Pharmaceutcials, Inc. Common Stock's Revenue (TTM)?
Eton Pharmaceutcials, Inc. Common Stock's Revenue (TTM) is $105.6M, based on as-reported figures from SEC (XBRL) filings.
What is Eton Pharmaceutcials, Inc. Common Stock's Net Income (TTM)?
Eton Pharmaceutcials, Inc. Common Stock's Net Income (TTM) is $12.7M, based on as-reported figures from SEC (XBRL) filings.
What is Eton Pharmaceutcials, Inc. Common Stock's EBITDA?
Eton Pharmaceutcials, Inc. Common Stock's EBITDA is $20.9M, based on as-reported figures from SEC (XBRL) filings.
What is Eton Pharmaceutcials, Inc. Common Stock's Diluted EPS (TTM)?
Eton Pharmaceutcials, Inc. Common Stock's Diluted EPS (TTM) is 0.44, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenues:
Total net revenues
YoY growth+98.6%+40.4%+82.7%+117.5%
Cost of sales:
Product sales and royalties, net
Gross profit
% of revenue67.6%60.7%61.6%35.0%
Operating expenses:
Research and development
General and administrative
Total operating expenses
% of revenue33.6%50.8%50.0%41.0%
Income (loss) from operations
% of revenue34.0%9.9%11.6%-6.1%
Other expense:
Interest and other expense, net—
Income (loss) before income tax expense
Income tax expense
Net income (loss)
% of revenue30.8%6.4%7.0%-8.6%
Net income (loss) per share, basic (in dollars per share)—
Net income (loss) per share, diluted (in dollars per share)—